Harvard Medical School (hms And Hsdm)

This study tested whether artificial intelligence (AI) could help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Doctors reviewed bone marrow samples with and without AI assistance to see if the technology improved thei…